St. Jude Credits Soaring ICD Sales To Its Product Line, Not Guidant Recall

St. Jude Medical says it will continue marketing its products with the assumption that Guidant's resynchronization defibrillators (CRT-D) will return to the market by the end of the third quarter

More from Archive

More from Medtech Insight